StonvexLoading…
StonvexStonvexStonvexCore line items from WU's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $3.88B | $4.03B | $4.16B | $4.25B |
Operating Income | $757.30M | $725.80M | $817.50M | $884.90M |
Net Income | $499.60M | $934.20M | $626.00M | $910.60M |
EPS (Diluted) | $1.52 | $2.74 | $1.68 | $2.34 |
Total Assets | $8.31B | $8.37B | $8.20B | $8.50B |
Total Liabilities | $7.35B | $7.40B | $7.72B | $8.02B |
Cash & Equivalents | $1.23B | $1.47B | $1.27B | $1.29B |
Free Cash Flow OCF − CapEx | $505.20M | $368.90M | $760.20M | $549.70M |
Shares Outstanding | 315.70M | 337.90M | 350.50M | 373.50M |